Efficacy and safety of clopidogrel in children with diarrhea associated hemolytic uremic syndrome

Thrombosis Research

Volumn 130, Issue 3, 2012, Pages

  Seltz, L Barry ^a   Bakel, Leigh Anne ^a   Tiehen, Jennifer ^a   Gao, Dexiang ^b   Cadnapaphornchai, Melissa A ^a   Lum, Gary ^a   Ford, Douglas ^a  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

^b Food Science and Human Nutrition   (United States)

Author keywords

Child; Clopidogrel; Dialysis; Hemolytic uremic syndrome; Platelet aggregation inhibitors

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; CREATININE; DIPYRIDAMOLE; DIURETIC AGENT; ERYTHROPOIETIN; FUROSEMIDE; HEMOGLOBIN; METOLAZONE; SULFINPYRAZONE;

ADOLESCENT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DIALYSIS; DIARRHEA; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; EPISTAXIS; ERYTHROCYTE TRANSFUSION; FEMALE; GROUPS BY AGE; HEMATEMESIS; HEMOLYTIC UREMIC SYNDROME; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRESCHOOL CHILD; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RISK FACTOR; SCHOOL CHILD; THROMBOCYTE COUNT; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIARRHEA; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INFANT; MALE; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84865234459     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.05.017     Document Type: Article

References (32)

1. J. Scheiring, S. Andreoli, and L. Zimmerhackl Treatment and outcome of shiga-toxin associated hemolytic uremic syndrome (HUS) Pediatr Nephrol 23 2008 1749 1760
2. P. Tarr, C. Gordon, and W. Chandler Shiga-toxin producing Escherichia coli and haemolytic uraemic syndrome Lancet 365 2005 1073 1086
3. A. Serna, and E. Boedeker Pathogenesis and treatment of shiga toxin-producing Escherichia coli infections Curr Opin Gastroenterol 24 2008 38 47
4. J. Scheiring, A. Rosales, and L. Zimmerhackl Today's understanding of the haemolytic uraemic syndrome Eur J Pediatr 169 2010 7 13
5. M. Franchini, M. Zaffanello, and D. Veneri Advances in the pathogenesis, diagnosis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome Thromb Res 118 2006 177 184
6. P. Ray, and X.H. Liu Pathogenesis of shiga toxin-induced hemolytic uremic syndrome Pediatr Nephrol 16 2001 823 839
7. C. Zoja, S. Buelli, and M. Morigi Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction Pediatr Nephrol 25 2010 2231 2240
8. C. Thorsen, E. Rossi, D. Green, and F. Carone The treatment of the hemolytic-uremic syndrome with inhibitors of platelet function Am J Med 66 1979 711 716
9. E. Arenson, and C. August Preliminary report: Treatment of the hemolytic-uremic syndrome with aspirin and dipyridamole J Pediatr 86 1975 957 961
10. C. Brown, J. Robson, D. Thomson, A. Clarkson, J. Cameron, and C. Ogg Haemolytic uraemic syndrome in women taking oral contraceptives Lancet 1 1973 1479 1481
11. H. Powell, and H. Ekert Streptokinase and anti-thrombotic therapy in the hemolytic-uremic syndrome J Pediatr 84 1974 345 349
12. R. Damme-Lombaerts, W. Proesmans, B. Damme, R. Eeckels, P. Muaka, and V. Mercieca Heparin plus dipyridamole in childhood hemolytic-uremic syndrome: A prospective, randomized study J Pediatr 113 1988 913 918
13. S. O'Regan, R. Chesney, J. Mongeau, and P. Robitaille Aspirin and dipyridamole therapy in the hemolytic uremic syndrome J Pediatr 97 1980 473 476
14. T. Yin, and T. Miyata Pharmacogenomics of clopidogrel: evidence and perspectives Thromb Res 128 2011 307 316
15. L. Mertens, B. Eyskens, D. Boshoff, and M. Gewillig Safety and efficacy of clopidogrel in children with heart disease J Pediatr 153 2008 61 64
16. Y. Finkelstein, L. Nurmohamed, M. Avner, L. Benson, and G. Koren Clopidogrel use in children J Pediatr 2005 657 661
17. T. Soman, M. Rafay, S. Hune, A. Allen, D. MacGregor, and G. deVeber The risks and safety of clopidogrel in pediatric arterial ischemic stroke Stroke 37 2006 1120 1122
18. L. Maltz, K. Gauvreau, J. Connor, and K. Jenkins Clopidogrel in a pediatric population: prescribing practice and outcomes from a single center Pediatr Cardiol 30 2009 99 105
19. F. Andersohn, F. Hagmann, and E. Garbe Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome associated with clopidogrel: report of two new cases Heart 90 2004 e57
20. S. Manor, G. Guillory, and S. Jain Clopidogrel-induced thrombotic thrombocytopenic purpura-hemolytic uremic syndrome after coronary artery stenting Pharmacotherapy 24 2004 664 667
21. B. May, J. Wang, G. Raffel, and J. Marcoux Hemolytic uremic syndrome associated with clopidogrel: a case report Arch Intern Med 160 2000 1370 1372
22. S. Balamuthusamy, and R. Arora Hematologic adverse effects of clopidogrel Am J Ther 14 2007 106 112
23. C. Bennett, J. Connors, J. Carwile, J. Moake, W. Bell, and S. Tarantolo Thrombotic thrombocytopenic purpura associated with clopidogrel N Engl J Med 342 2000 1773 1777
24. A. Schifferli, R. von Vigier, M. Fontana, G. Sparta, H. Schmid, and M. Bianchetti The Swiss Pediatric Surveillance Unit. Hemolytic-uremic syndrome in Switzerland: a nationwide surveillance 1997-2003 Eur J Pediatr 169 2010 591 598
25. The Escape Trial Group Strict blood-pressure control and progression of renal failure in children N Engl J Med 361 2009 1639 1650
26. A. Staples, R. LeBlond, S. Watkins, C. Wong, and J. Brandt Validation of the revised Schwartz estimation equation in a predominantly non-CKD population Pediatr Nephrol 25 2010 2321 2326
27. M. Michael, E. Elliott, J. Craig, G. Ridley, and E. Hodson Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials Am J Kidney Dis 53 2009 259 272
28. A. Gerber, H. Karch, F. Allerberger, F. Verweyen, and L. Zimmerhackl Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study J Infect Dis 186 2002 493 500
29. D. Matsell, and C. White An outbreak of diarrhea-associated childhood hemolytic uremic syndrome: the Walkerton epidemic Kidney Int Suppl 75 2009 S35 S37
30. J. Fong, and B. Kaplan Impairment of platelet aggregation in hemolytic uremic syndrome: evidence for platelet "exhaustion" Blood 60 1982 564 570
31. V. Fuster, and J. Sweeny Clopidogrel and the reduced-function CYP2C19 genetic variant. A limited piece of the overall therapeutic puzzle JAMA 304 2010 1839 1840
32. A. Garg, R. Suri, N. Barrowman, F. Rehman, D. Matsell, and M. Rosas-Arellano Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome. A systematic review, meta-analysis, and meta-regression JAMA 290 2003 1360 1370